{"id":"NCT02046616","sponsor":"Hoffmann-La Roche","briefTitle":"A Study of Subcutaneous (SC) Tocilizumab (RoActemra/Actemra) in Participants With Active Rheumatoid Arthritis (RA) and Inadequate Response to Disease-Modifying Anti-Rheumatic Drugs (DMARDs)","officialTitle":"Tocilizumab SC in Patients With Active Rheumatoid Arthritis and Inadequate Response to DMARDs. A Single-Arm, Open-Label Study to Evaluate Safety, Tolerability and Efficacy. In a Subgroup of Patients Inflammation Will Be Measured by Ultrasound.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-05-28","primaryCompletion":"2016-09-13","completion":"2016-09-13","firstPosted":"2014-01-28","resultsPosted":"2018-04-13","lastUpdate":"2018-04-13"},"enrollment":133,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Rheumatoid Arthritis"],"interventions":[{"type":"DRUG","name":"Tocilizumab","otherNames":["RoActemra, Actemra"]},{"type":"DRUG","name":"Methotrexate","otherNames":[]},{"type":"DRUG","name":"Non-Biologic DMARDs","otherNames":[]}],"arms":[{"label":"Tocilizumab Alone or Combined with Methotrexate or Other DMARD","type":"EXPERIMENTAL"}],"summary":"This Phase IIIb, open-label, single-arm study will evaluate the safety, efficacy, and tolerability of SC tocilizumab (RoActemra/Actemra) in monotherapy or in combination with methotrexate or other non-biologic DMARDs in participants with active RA who are naive to tocilizumab. Participants will receive tocilizumab 162 milligrams (mg) subcutaneously weekly (QW) for 24 weeks.","primaryOutcome":{"measure":"Change From Baseline in Clinical Disease Activity Index (CDAI) at Week 12","timeFrame":"Baseline, Week 12","effectByArm":[{"arm":"Tocilizumab Alone or Combined With Methotrexate or Other DMARD","deltaMin":24.9,"sd":10.5}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":7,"exclusionCount":18},"locations":{"siteCount":27,"countries":["Denmark","Finland","Norway","Sweden"]},"refs":{"pmids":["34131623","33464147","30649524","29244149"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":12,"n":133},"commonTop":["Nasopharyngitis","Hypertension","Nausea","Upper respiratory tract infection","Rash"]}}